Brief Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jan 28, 2009; 15(4): 449-456
Published online Jan 28, 2009. doi: 10.3748/wjg.15.449
Table 2 Incidence of chemotherapy-related toxicities
Treatment group
CAPIRI (n = 17)CAPIRI-Bev (n = 29)
NCI-CTC GradeTotal (1-4)3-4Total (1-4)3-4
Hematologic toxicities, number (%) patients
Anemia2 (11.8)1 (5.9)4 (13.8)-
Leukopenia4 (23.5)2 (11.8)6 (20.7)1 (3.4)
Neutropenia3 (17.6)1 (5.9)5 (17.2)2 (6.9)
Non-hematologic toxicities, number (%) patients
Diarrhea7 (41.2)5 (29.4)13 (44.8)5 (17.2)
Nausea/vomiting6 (35.3)-12 (41.4)2 (6.9)
Hand-foot syndrome6 (35.3)1 (5.9)9 (31.0)-
Mucositis3 (17.3)2 (11.8)5 (17.2)-
Cholinergic syndrome3 (17.3)-2 (6.9)-
Alopecia12 (11.8)-12 (41.4)-
Fatigue2 (11.8)-10 (34.5)-
Anorexia1 (5.9)1 (5.9)2 (6.9)1 (3.4)
Fever1 (5.9)-4 (13.8)-
Proteinuria1--7 (24.1)1 (3.4)
Arterial hypertension--3 (10.3)-
Cardiovascular1 (5.9)-1 (3.4)1 (3.4)
Thromboembolic event--3 (10.3)-
GGT rise1 (5.9)-4 (13.8)4 (13.8)
Hypokalemia1 (5.9)1 (5.9)3 (10.3)-
Creatinine rise1 (5.9)-1 (3.4)-